• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Alternative lung cancer screening criteria may increase sensitivity versus current guidelines

byJunghoon KoandThomas Su
August 19, 2024
in Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this modeling study, an alternative set of lung cancer screening criteria was more sensitive and specific overall in identifying high-benefit people as compared to the current United States Preventive Services Task Force criteria.

2. The alternative criteria were also more sensitive in identifying high-benefit people among racial and ethnic minorities.

Evidence Rating Level: 2 (Good)

Study Rundown: Lung cancer is the leading cause of cancer-related mortality in the United States, with the most significant risk factor being smoking. The current guidelines from the United States Preventive Services Task force (USPSTF) recommend lung cancer screening for individuals who are between 50 and 80 years of age, have a smoking history of at least 20 pack-years, and are current smokers or have quit within the last 15 years. However, recent studies suggest that the criteria endorsed by the USPSTF may exclude a significant number of individuals who would benefit from screening, including those from marginalized races or ethnic groups. Multivariable prediction models which account for the total life expectancy gained from screening may help to reduce this issue, but clinical implementation of such prediction models remains a challenge. Hence, this study developed alternative simple lung cancer screening criteria and compared their performance against the current USPSTF criteria in identifying high-benefit people in the United States between the ages of 40 and 80 years with any amount of smoking history. The final alternative criteria included individuals who had either smoked any amount yearly for at least 40 years or people between the ages of 60 and 80 years with at least a 40-pack-year smoking history. Overall, the alternative criteria were more sensitive and specific in identifying high-benefit people compared to the USPSTF criteria. Moreover, the alternative criteria were more sensitive in identifying high-benefit people among racial and ethnic minorities, including Black, Hispanic, and Asian individuals. The study results were limited by the nature of its design, which utilized model-based projections.

Click to read the study in AIM

Relevant Reading: Screening for lung cancer U.S. Preventive Services Task Force recommendation statement

RELATED REPORTS

Low-Dose CT for Lung Cancer Screening in a High-Risk Population

Racial disparities may exist in access to lung cancer screening facilities

Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective

In-Depth [retrospective cohort]: This study used model-based projections to derive alternative simple criteria for lung cancer screening and compared them with the current USPSTF criteria in their ability to identify high-benefit individuals in the United States. All individuals from 40 to 80 years of age with a history of smoking based on the annual National Health Interview Survey (NHIS) from 1997 to 2018 were included. Using the life-years gained from screening computed tomography (LYFS-CT) model, “high-benefit” individuals were defined as those who would gain at least 16.2 days of life from 3 annual screens as recommended by the American College of Chest Physicians (CHEST). The final alternative criteria, which were derived using “fast-and-frugal trees,” included individuals who had either smoked any amount yearly for at least 40 years or those between the ages of 60 and 80 years with at least 40-pack-years of smoking. The LYFS-CT model was adjusted to enhance eligibility for individuals from disadvantaged racial or ethnic groups when their race had shorter life expectancy than White individuals. Overall, the alternative criteria and the USPSTF criteria chose a nearly identical population size for screening (14.1 million people), but the alternative criteria exhibited increased sensitivity (91% vs 78%; P<0.001) and increased specificity (86% vs 84%; P<0.001) for identifying high-benefit individuals. The alternative criteria also exhibited increased sensitivity in identifying high-benefit people among racial and ethnic minorities as compared to the USPSTF criteria (Black: 83% vs 56% [P<0.001]; Hispanic: 95% vs 73% [P=0.086]; Asian: 94% vs 68% [P=0.171]), as well as those who had smoked at lower doses for longer durations (less than 20 pack-years over at least 40 years) and had longer quit histories (greater than 15 years). In summary, this study demonstrated that alternative simple lung cancer screening criteria may be more sensitive in identifying high-benefit people compared to the guidelines published by the USPSTF.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: lung cancer screeningmodeling studyracial disparities
Previous Post

Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma

Next Post

The Scan by 2 Minute Medicine®: Competition and COVID, Anti-Anaphylaxis, Pulling the Plug on Psychedelics and POTS in the Pool:

RelatedReports

Cancer to surpass heart disease as leading cause of death in the U.S. for higher-income persons
Chronic Disease

Low-Dose CT for Lung Cancer Screening in a High-Risk Population

March 31, 2025
Institute of Medicine identifies cost variation between geographic regions
Oncology

Racial disparities may exist in access to lung cancer screening facilities

January 17, 2025
AAP releases 2016 recommendations for childhood and adolescent immunizations
Public Health

Expanding human papillomavirus vaccination to high-risk mid-adults may be cost-effective

November 26, 2024
Significant reduction in prostate screening rates after revised guidelines
Public Health

Novel colorectal cancer screening tests’ utility depends on patient context

November 4, 2024
Next Post
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Competition and COVID, Anti-Anaphylaxis, Pulling the Plug on Psychedelics and POTS in the Pool:

#VisualAbstract Molecular Guided Therapy Improves Survival for Unfavourable Cancer of Unknown Origin

#VisualAbstract Molecular Guided Therapy Improves Survival for Unfavourable Cancer of Unknown Origin

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

#VisualAbstract: Site-Specific Therapy Guided by a 90-Gene Expression Assay Improved Survival in Patients with Cancer of Unknown Primary

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous hydrocortisone may reduce risk of kidney failure in patients with sepsis
  • Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension
  • Oral semaglutide reduces cardiovascular event rates in high-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.